The ASA Biopharmaceutical Section Nonclinical Biostatistics Working Group is accepting nominations for the 2021 Stan Altan Nonclinical Biostatistics Paper Award.
The paper must address a relevant topic in “nonclinical biostatistics,” but the scope is broad and generally includes everything but topics directly related to clinical trials. This would span (but not be limited to) topics covered in the book Nonclinical Biostatistics for Pharmaceutical and Biotechnology Industries. Topics such as biomarker discovery, machine learning, and AI, which do not directly concern trial design (phase I–IV), are also welcome.
All eligible papers must have been published (or been accepted for publication) in an English-language refereed journal between January 1, 2014, and March 1, 2021. Send an electronic copy of your paper to Jason Zhang and include contact information for all co-authors (e.g., email addresses). Submissions are due March 15, 2021.
The best paper award will be presented to the winning author(s) at the 2021 Nonclinical Biostatistics Conference at Rutgers University. Due to COVID-19, the award may be mailed to recipients directly.
Leave a Reply